News
“We’ve stepped back into the world that we lived in before the [CDC’s vaccine advisory committee] was created,” said Dr.
The Food and Drug Administration is considering pulling its authorization of Pfizer’s COVID-19 vaccine for healthy children ...
Diagnostics' progress on their PCR platform, with key trials in 2025 and commercialization plans by 2026, targeting U.S. and global markets.
Key Points GAAP revenue jumped 413% year over year to $11.8 million in Q2 2025, but fell far short of analyst estimates, with GAAP revenue of $11.8 million missing the consensus of $23.2 million by 49 ...
An Iowa pharmacy that has been sued by business partners for millions of dollars is now being sanctioned by the state for ...
5h
TipRanks on MSNInvivyd Aligns with FDA for Rapid Approval Pathway
Invivyd ( ($IVVD) ) just unveiled an update. On August 14, 2025, Invivyd announced its alignment with the U.S. FDA on a rapid pathway to full ...
With the latest COVID-19 surge, information on testing and vaccinations for those who are uninsured is becoming hard to find.
KSWB-TV San Diego on MSN6h
FDA could soon restrict COVID-19 shots for young kids
The FDA says they are considering ending authorization for healthy children between 6 months and 5 years old. Melania Trump ...
The U.S. Food and Drug Administration may not renew its authorization for Pfizer's COVID-19 vaccine approved for children ...
The Trump administration’s COVID-revenge campaign has laid the groundwork for Kennedy’s larger agenda.
This explainer discusses what ACIP does, how it makes recommendations, and how administration actions may affect Americans’ ...
Doctors and public health leaders recommend that most people 6 months old and older get the 2025-26 flu vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results